Benchmark Upgrades BioLife Solutions (BLFS) to Buy
- Wall Street ends week positively; S&P 500, Dow hit record highs
- Bitcoin (BTC) Drops 3% as Turkey Bans Cryptocurrency Payments Citing Lack of Regulatory Supervision
- Morgan Stanley (MS) Archegos-Related Loss Appears to be $911M
- Dollar at 4-week low on retreating Treasury yields
Benchmark analyst Robert Wasserman upgraded BioLife Solutions (NASDAQ: BLFS) from Hold to Buy with a price target of $54.00.
Shares of BioLife Solutions closed at $38.57 yesterday.
You May Also Be Interested In
- Nomura/Instinet Upgrades Wipro Ltd. (WPRO:IN) (WIT) to Neutral
- Goldman Sachs Upgrades Beach Energy Ltd (BPT:AU) (BEPTF) to Neutral
- TD Securities Upgrades Kirkland Lake Gold (KL:CN) (KL) to Action List Buy